European Union Greenlights BioNTech-Pfizer COVID-19 Vaccine After Agency Gives Safety Approval
(AMSTERDAM) — The European Union on Monday gave official approval for the coronavirus vaccine developed by BioNTech and Pfizer to be used across the 27-nation bloc, raising hopes that countries can begin administering the first shots to their citizens shortly after Christmas. The EU’s executive commission gave the green light just hours after the European Medicines Agency said the vaccine meets safety and quality standards. Brussels had been expected to take two or three days to endorse the market authorization move. “As we have promised, this vaccine will be available for all EU countries at the same tim...
Source: TIME: Health - December 21, 2020 Category: Consumer Health News Authors: ALEKSANDAR FURTULA and FRANK JORDANS / AP Tags: Uncategorized COVID-19 wire Source Type: news
The Good, the Bad and the Ugly
By Joaquín RoyMIAMI, Jul 31 2020 (IPS) In the cinematic context of the death of the Italian and universal composer, Ennio Morricone, author of the background music of more than four hundred films, as an indirect tribute, Europe took a solid step. The European Union’s (EU) forceful ban on accepting travelers from the rest of the world has been decided simultaneously with a collective option: an internal opening that covers the entire territory of the Schengen Agreement, an enlarged EU that includes some special non-members (Switzerland, Norway, Iceland, Liechtenstein and the microstates). Furthermore, the EU s...
Source: IPS Inter Press Service - Health - July 31, 2020 Category: International Medicine & Public Health Authors: Joaquin Roy Tags: Global Geopolitics Headlines Health Source Type: news
U.S. Citizens Likely to Be Barred as Europe Reopens Borders for Travel, Tourism
(BRUSSELS) — Americans are unlikely to be allowed into Europe when the continent reopens its borders next week, due to how the coronavirus pandemic is flaring in the U.S. and President Donald Trump’s ban on Europeans entering the United States. European nations appear on track to reopen their borders between each other by July 1, and their representatives in Brussels are now debating what virus-related criteria should apply when lifting border restrictions to the outside world that were imposed in March. Read more: Mapping the Spread of the Coronavirus Outbreak Around the U.S. and the World In recommendations ...
Source: TIME: Health - June 24, 2020 Category: Consumer Health News Authors: LORNE COOK / AP Tags: Uncategorized COVID-19 europe News Desk wire Source Type: news
Personal protective equipment (PPE): export control process,DHSC (updated 29th April 2020)
During the coronavirus (COVID-19) outbreak, anyone wishing to export personal protective equipment () to areas outside the EU, European Free Trade Association member states (Iceland, Liechtenstein, Norway, Switzerland) and certain other territories will temporarily need a export licence.This guidance sets out the exporting restrictions on products and the export control process now in place, including how economic operators can apply for a licence. 29 April 2020 The 3 attachments on this page have been updated to reflect the revised EU regulations. The attachments are:'Personal protective equipment (PPE): export contr...
Source: Current Awareness Service for Health (CASH) - April 29, 2020 Category: Consumer Health News Source Type: news
Liechtenstein rolls out radical Covid-19 bracelet programme
Biometric wristbands will measure vital signs to detect early indicators of infection (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 16, 2020 Category: Pharmaceuticals Source Type: news
Veterinary scientist hailed for Faroe Islands' lack of Covid-19 deaths
Debes Christiansen adapted his salmon-testing lab to test for disease among humansCoronavirus – latest updatesSee all our coronavirus coverageA scientist who adapted his veterinary lab to test for disease among humans rather than salmon is being celebrated for helping the Faroe Islands avoid coronavirus deaths, where a larger proportion of the population has been tested than anywhere in the world.The north Atlantic archipelago currently has only one person in hospital with Covid-19 and it is one of four European countries, along with Georgia, Malta and Liechtenstein to so far not have any deaths from the virus.Contin...
Source: Guardian Unlimited Science - April 8, 2020 Category: Science Authors: Daniel Boffey in Brussels Tags: Faroe Islands Coronavirus outbreak World news Infectious diseases Science Medical research Source Type: news
Settled status: UNISON can help
After the EU referendum the government decided to introduce a new immigration status for EU citizens called ‘settled status’. What does this mean? People who are citizens or have a passport of a European Union member state, or Iceland, Liechtenstein, Norway or Switzerland, and are in the UK by the 31 December 2020, are required to apply (along with family members) to the EU settlement scheme to continue living and working in the UK after 30 June 2021. The Home Office campaign does not cover the full range of citizens who can apply under the scheme. The messaging is centred on “white” EU/EEA/Swiss c...
Source: UNISON meat hygiene - November 21, 2019 Category: Food Science Authors: Janey Starling Tags: Article BREXIT EU EU Citizens eu migrant migrant workers Source Type: news
Characterization of Leachates from 6 Root Canal Sealers
Journal of EndodonticsPublication HistoryPublished online:March 21, 2019 AbstractIntroductionThe aim of this study was to evaluate 6 different endodontic sealers by characterizing their leachates and comparing their solubility in water over a 4-week period.MethodsThe solubility of each sealer (Apexit Plus [Ivoclar Vivadent AG, Schaan, Liechtenstein], MTA Fillapex [Angelus Dental, Londrina, Brazil], AH Plus [Dentsply DeTrey, Konstanz, Germany], BioRoot RCS [Septodont, Saint-Maur-des-Foss és, France], Total Fill [FKG Dentaire SA, La Chaux-de-Fonds, Switzerland], and Obturys [Itena, Paris, France]) was tested...
Source: Dental Technology Blog - April 1, 2019 Category: Dentistry Source Type: news
Delcath inks European licensing deal for Chemosat
Delcath Systems (OTC:DCTH) said this week that it inked a licensing deal with Germany-based medac for the commercialization of Chemosat in Europe. According to the terms of the seven-year agreement, Delcath’s European subsidiary will exclusively license its Chemosat system to Medac for sale in the EU, Norway, Liechtenstein, Switzerland and the UK. Medac is slated to pay $6.8 million to Delcath in a combination of upfront and milestone payments. Get the full story at our sister site, Drug Delivery Business News. The post Delcath inks European licensing deal for Chemosat appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 26, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Oncology Wall Street Beat Delcath Systems Inc. Source Type: news
Elekta taps Brainlab as select EU distro partner for stereotactic neuro devices
Elekta (STO:EKTA B) said today it tapped Brainlab to distribute its stereotactic neurological devices across select markets in the European Union. The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance in the US, Elekta added. The agreement also covers the Leksell Stereotactic system and Elekta Microdrive. “Elekta is a leader of equipment for stereotactic neurosurgery and Brainlab has a strong presence in t...
Source: Mass Device - June 29, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Neurological Surgical Brainlab Elekta AB Source Type: news
Fluid glass in windows which could provide an energy
In Liechtenstein a project is developing windows which could provide a source of energy. The outer face of the window is able to collect solar radiation and transform it into energy and the inner face is able to cool or heat the space inside the container. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - May 17, 2017 Category: Research Source Type: news
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Seattle Genetics’s treatment for high-risk Hodgkin lymphoma patients can now be marketed in Europe. Seattle Genetics (Nasdaq: SGEN) says its global distribution partner Takeda Pharmaceutical Co. has received permission from the European Commission to market Adcetris in 28 EU member countries and Norway, Liechtenstein and Iceland. Adcetris is already commercially available in more than 60 countries around the world, including throughout the EU for two other uses — relapsed Hodgkin lymphoma and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 6, 2016 Category: Pharmaceuticals Authors: Becky Monk Source Type: news
What will Brexit mean for medical device companies?
By Ronald Boumans, Emergo Group In a stunning referendum on June 23, UK voters decided to leave the European Union (EU). This historic vote has many medical device companies – inside and outside the UK – wondering what the future holds for the regulation of devices and IVDs sold in the country. The UK’s top medical device regulator – the MHRA – issued this statement, in which they say that they expect to keep doing their work as usual. Under the current regulatory framework, companies selling medical devices in the UK must abide by Europe’s medical device, IVD or active implan...
Source: Mass Device - June 27, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Emergo Group Source Type: news
Here's Why 'Brexit' Could Be A British Public Health Disaster
Britons voted on the "Brexit" referendum on Thursday to decide whether to exit the European Union. Ballots aren't yet tallied, but the result is likely to hinge on voter opinion about immigration. Officially, the referendum is about the pros and cons of remaining in the EU, an economic partnership between the 28 member countries that allows people, goods and information to move easily through the region. A possible exit from this partnership would have an impact on issues as wide-ranging as the economy, scientific research, the labor force, British vacation time and the future of the British territory o...
Source: Healthy Living - The Huffington Post - June 23, 2016 Category: Consumer Health News Source Type: news
Climate Deception: Non-binding "Targets" for Climate, but Binding Rules on Trade in Services
The whole world is watching as world leaders from nearly every country across the globe meet in Paris this week to set carbon emission reductions targets to address global climate change. Unfortunately representatives of 50 of the same governments are also meeting this week in Geneva to negotiate binding rules that will seriously constrain countries' ability to meet those targets. The 15th round of talks to create a "Trade in Services Agreement," or TiSA, are occurring once again in Geneva. Members of the TiSA currently include Australia, Canada, Chile, Colombia, Costa Rica, Hong Kong, Iceland, Israel, Japan, L...
Source: Science - The Huffington Post - December 4, 2015 Category: Science Source Type: news
Elocta Approved in Europe for Hemophilia AElocta Approved in Europe for Hemophilia A
The European Commission has approved Elocta for the treatment of hemophilia A in all 28 European Union member states, Iceland, Liechtenstein, and Norway. International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 25, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Gilead's Hepatitis C Treatment Sofosbuvir Gets European Commission Nod
Gilead Sciences’ Sofosbuvir, a hepatitis C treatment potentially faster and more effective than current therapies, has been approved by the European Commission. The European Commission approval predicates marketing rights for Gilead in all European Union countries including European Economic Area countries Iceland, Norway, and Liechtenstein. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - January 21, 2014 Category: Pharmaceuticals Source Type: news
Bavarian Nordic receives European marketing authorization for Imvanex smallpox vaccine
Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has granted marketing authorization for IMVANEX® (MVA-BN) for active immunization against smallpox disease for the general adult population, including people with weakened immune systems (people diagnosed with HIV or atopic dermatitis). The authorization covers all 27 European Union member states and European Economic Area countries Iceland, Liechtenstein and Norway. IMVANEX will be made available for governments to purchase and use in accordance with official national recommendations... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 9, 2013 Category: Consumer Health News Tags: Regulatory Affairs / Drug Approvals Source Type: news